Penn biopharma spinout closes $12M financing

Posted on September 20, 2019 — Jessica Jones Gupta

Linnaeus Therapeutics is a development stage biotech company engaged in the identification and development of small molecule agents for the treatment of cancer. Read more. (Philadelphia Business Journal)

What’s hot with VC investors: Lessons from the commercialization speaker series with Barbara Schilberg

Posted on September 19, 2019 — Jessica Jones Gupta

PCI and Penn Medicine were pleased to have Barbara Schilberg of BioAdvance kick off the 2019 fall lunchtime speaker series.  Barbara has more than 30 years of experience working with academic technologies and start-up companies in the life sciences sector.   Her topic, What’s Hot with VC Investors, attracted one of the largest audiences to…

OVPR opened its doors to the Penn community

Posted on — Jessica Jones Gupta

On Tuesday, September 17, 2019, the Office of the Vice Provost for Research celebrated its new offices at 3600 Civic Center Blvd. by opening its doors to the Penn community and partners. The first annual Navigating Commercialization @ Penn Open House was a huge success, with 110 attendees from all Penn schools and major partners….

The redemption of James Wilson, gene therapy pioneer

Posted on September 13, 2019 — Jessica Jones Gupta

A deep look into the history of gene therapy through the work of Penn’s Dr. James Wilson. Read more. (Chemical & Engineering News)

Philly’s Mini Maker Faire for local inventors and crafters returns this October

Posted on September 9, 2019 — Jessica Jones Gupta

Despite the national organization shutting down earlier this year, the Philly chapter of the Maker Faire will return to Pennovation next month — and hopes to double attendance. Read More. (Technical.ly Philly)

Alzheimer’s pioneer Virginia Lee wins $3 million Breakthrough Prize for work at Penn

Posted on September 5, 2019 — Jessica Jones Gupta

Virginia Lee, director of the Center for Neurodegenerative Disease Research at Penn’s Perelman School of Medicine, was awarded one of seven $3 million Breakthrough Prizes. Read More (Philadelphia Inquirer)

Gene therapy startup Passage Bio raises $110M Series B, its second raise in less than a year

Posted on September 4, 2019 — Jessica Jones Gupta

Philadelphia-based novel gene therapy startup Passage Bio says it closed a $110 million Series B round of funding, less than seven months after raising a $115.5 million Series A. The company’s latest round of funding was led by Access Biotechnology, with participation from existing investors OrbiMed, Frazier Healthcare Partners, Versant Ventures, Lily Asia Ventures, New…